MYD88 and diffuse large B-cell lymphoma: Previous reports indicated that 39% of ABC-DLBCL cases exhibit a mutant isoform of MyD88 with a leucine to proline substitution at position 265 (L265P), similar to the resequencing of MyD88 in DLBCL clinical samples.